Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

4.11
Delayed Data
As of Mar 24
 -0.04 / -0.96%
Today’s Change
2.63
Today|||52-Week Range
6.30
+13.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues8.0M5.7M3.1M2.5M
 
 
 
 
 
Depreciation And Amortization20.0K29.0K27.0K11.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses39.7M50.7M42.3M39.0M
 
 
 
 
 
Research And Development28.9M27.7M23.7M22.9M
 
 
 
 
 
Total Operating Expenses39.7M50.8M42.4M39.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-31.8M-45.0M-39.3M-36.5M
 
 
 
 
 
Extraordinary Credit96.0K3.9M3.5M0.00
 
 
 
 
Interest Expense On Debt2.9M1.7M939.0K1.7M
 
 
 
 
 
Other Expenses-4.0K-132.0K22.0K158.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-34.6M-43.0M-36.7M-38.0M
 
 
 
 
 
Net Income-34.6M-43.0M-36.7M-38.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.7M10.0M12.2M15.7M
 
 
 
 
 
Shares To Calculate EPS Diluted8.7M10.3M12.2M15.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.96-$4.56-$3.00-$2.42
 
 
 
 
 
EPS Diluted-$3.96-$4.56-$3.00-$2.42